Surgical resection of lung metastases: results from 529 patients

Detalhes bibliográficos
Autor(a) principal: Younes, Riad N.
Data de Publicação: 2009
Outros Autores: Gross, Jefferson L., Taira, Andrea M., Martins, Andrea Aparecida C., Neves, Giuliana Sigolo
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Clinics
Texto Completo: https://www.revistas.usp.br/clinics/article/view/18052
Resumo: OBJECTIVE: The aim of this study is to determine clinical, pathological, and treatment-relevant variables associated with long-term (90-month) overall survival in patients with lung metastases undergoing pulmonary metastasectomy. METHODS: A retrospective review was performed of patients who were admitted with lung metastases, and who underwent thoracotomy for resection, after treatment of a primary tumor. Data were collected regarding demographics, tumor features, treatment, and outcome. RESULTS: Patients (n = 529) were submitted to a total of 776 thoracotomies. Median follow-up time across all patients was 21.6 months (range: 0-192 months). The postoperative complication rate was 9.3%, and the 30-day mortality rate was 0.2%. The ninety-month overall survival rate for all patients was 30.4%. Multivariate analysis identified the number of pulmonary nodules detected on preoperative CT-scan, the number of malignant nodules resected, and complete resection as the independent prognostic factors for overall survival. CONCLUSION: These results confirm that lung metastasectomy is a safe and potentially curative procedure for patients with treated primary tumors. A select group of patients can achieve long-term survival after resection.
id USP-19_8c254f1a3f4e7d61bac75146b214ed78
oai_identifier_str oai:revistas.usp.br:article/18052
network_acronym_str USP-19
network_name_str Clinics
repository_id_str
spelling Surgical resection of lung metastases: results from 529 patients LungMetastasesResectionMetastasectomyPrognostic factors OBJECTIVE: The aim of this study is to determine clinical, pathological, and treatment-relevant variables associated with long-term (90-month) overall survival in patients with lung metastases undergoing pulmonary metastasectomy. METHODS: A retrospective review was performed of patients who were admitted with lung metastases, and who underwent thoracotomy for resection, after treatment of a primary tumor. Data were collected regarding demographics, tumor features, treatment, and outcome. RESULTS: Patients (n = 529) were submitted to a total of 776 thoracotomies. Median follow-up time across all patients was 21.6 months (range: 0-192 months). The postoperative complication rate was 9.3%, and the 30-day mortality rate was 0.2%. The ninety-month overall survival rate for all patients was 30.4%. Multivariate analysis identified the number of pulmonary nodules detected on preoperative CT-scan, the number of malignant nodules resected, and complete resection as the independent prognostic factors for overall survival. CONCLUSION: These results confirm that lung metastasectomy is a safe and potentially curative procedure for patients with treated primary tumors. A select group of patients can achieve long-term survival after resection. Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo2009-06-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://www.revistas.usp.br/clinics/article/view/1805210.1590/S1807-59322009000600008Clinics; Vol. 64 No. 6 (2009); 535-541 Clinics; v. 64 n. 6 (2009); 535-541 Clinics; Vol. 64 Núm. 6 (2009); 535-541 1980-53221807-5932reponame:Clinicsinstname:Universidade de São Paulo (USP)instacron:USPenghttps://www.revistas.usp.br/clinics/article/view/18052/20117Younes, Riad N.Gross, Jefferson L.Taira, Andrea M.Martins, Andrea Aparecida C.Neves, Giuliana Sigoloinfo:eu-repo/semantics/openAccess2012-05-22T18:53:22Zoai:revistas.usp.br:article/18052Revistahttps://www.revistas.usp.br/clinicsPUBhttps://www.revistas.usp.br/clinics/oai||clinics@hc.fm.usp.br1980-53221807-5932opendoar:2012-05-22T18:53:22Clinics - Universidade de São Paulo (USP)false
dc.title.none.fl_str_mv Surgical resection of lung metastases: results from 529 patients
title Surgical resection of lung metastases: results from 529 patients
spellingShingle Surgical resection of lung metastases: results from 529 patients
Younes, Riad N.
Lung
Metastases
Resection
Metastasectomy
Prognostic factors
title_short Surgical resection of lung metastases: results from 529 patients
title_full Surgical resection of lung metastases: results from 529 patients
title_fullStr Surgical resection of lung metastases: results from 529 patients
title_full_unstemmed Surgical resection of lung metastases: results from 529 patients
title_sort Surgical resection of lung metastases: results from 529 patients
author Younes, Riad N.
author_facet Younes, Riad N.
Gross, Jefferson L.
Taira, Andrea M.
Martins, Andrea Aparecida C.
Neves, Giuliana Sigolo
author_role author
author2 Gross, Jefferson L.
Taira, Andrea M.
Martins, Andrea Aparecida C.
Neves, Giuliana Sigolo
author2_role author
author
author
author
dc.contributor.author.fl_str_mv Younes, Riad N.
Gross, Jefferson L.
Taira, Andrea M.
Martins, Andrea Aparecida C.
Neves, Giuliana Sigolo
dc.subject.por.fl_str_mv Lung
Metastases
Resection
Metastasectomy
Prognostic factors
topic Lung
Metastases
Resection
Metastasectomy
Prognostic factors
description OBJECTIVE: The aim of this study is to determine clinical, pathological, and treatment-relevant variables associated with long-term (90-month) overall survival in patients with lung metastases undergoing pulmonary metastasectomy. METHODS: A retrospective review was performed of patients who were admitted with lung metastases, and who underwent thoracotomy for resection, after treatment of a primary tumor. Data were collected regarding demographics, tumor features, treatment, and outcome. RESULTS: Patients (n = 529) were submitted to a total of 776 thoracotomies. Median follow-up time across all patients was 21.6 months (range: 0-192 months). The postoperative complication rate was 9.3%, and the 30-day mortality rate was 0.2%. The ninety-month overall survival rate for all patients was 30.4%. Multivariate analysis identified the number of pulmonary nodules detected on preoperative CT-scan, the number of malignant nodules resected, and complete resection as the independent prognostic factors for overall survival. CONCLUSION: These results confirm that lung metastasectomy is a safe and potentially curative procedure for patients with treated primary tumors. A select group of patients can achieve long-term survival after resection.
publishDate 2009
dc.date.none.fl_str_mv 2009-06-01
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://www.revistas.usp.br/clinics/article/view/18052
10.1590/S1807-59322009000600008
url https://www.revistas.usp.br/clinics/article/view/18052
identifier_str_mv 10.1590/S1807-59322009000600008
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv https://www.revistas.usp.br/clinics/article/view/18052/20117
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo
publisher.none.fl_str_mv Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo
dc.source.none.fl_str_mv Clinics; Vol. 64 No. 6 (2009); 535-541
Clinics; v. 64 n. 6 (2009); 535-541
Clinics; Vol. 64 Núm. 6 (2009); 535-541
1980-5322
1807-5932
reponame:Clinics
instname:Universidade de São Paulo (USP)
instacron:USP
instname_str Universidade de São Paulo (USP)
instacron_str USP
institution USP
reponame_str Clinics
collection Clinics
repository.name.fl_str_mv Clinics - Universidade de São Paulo (USP)
repository.mail.fl_str_mv ||clinics@hc.fm.usp.br
_version_ 1800222754776023040